Actively Recruiting
CAR-T Long Term Follow Up (LTFU) Study
Led by Novartis Pharmaceuticals · Updated on 2025-10-28
1400
Participants Needed
118
Research Sites
1059 weeks
Total Duration
On this page
Sponsors
N
Novartis Pharmaceuticals
Lead Sponsor
U
University of Pennsylvania
Collaborating Sponsor
AI-Summary
What this Trial Is About
Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapied for 15 years following their last CAR-T (e.g. CTL019) infusion to assess the risk of delayed adverse events (AEs), monitor for replication competent lentivirus (RCL) and assess long-term efficacy, including vector persistence.
CONDITIONS
Official Title
CAR-T Long Term Follow Up (LTFU) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have received CAR-T therapy and completed or discontinued early from a Novartis sponsored treatment protocol or any CAR-T trial by the University of Pennsylvania partnered with Novartis
- Patients who have given informed consent before joining the long term follow-up study
You will not qualify if you...
- There are no specific exclusion criteria for this study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 118 locations
1
Mayo Clinic Arizona
Phoenix, Arizona, United States, 85054
Completed
2
City of Hope National Medical Center
Duarte, California, United States, 91010 3000
Actively Recruiting
3
Childrens Hospital Los Angeles
Los Angeles, California, United States, 90027
Actively Recruiting
4
UCLA Medical Center
Los Angeles, California, United States, 90095
Actively Recruiting
5
UCSF Medical Center
San Francisco, California, United States, 94143
Actively Recruiting
6
Stanford University Medical Center
Stanford, California, United States, 94304
Actively Recruiting
7
Emory University School of Medicine-Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
8
Emory University School of Medicine/Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
9
Childrens Healthcare of Atlanta
Atlanta, Georgia, United States, 30342
Actively Recruiting
10
Uni of Chi Medi Ctr Hema and Onco
Chicago, Illinois, United States, 60637
Actively Recruiting
11
University of Chicago Medical Center, Hematology & Oncology
Chicago, Illinois, United States, 60637
Actively Recruiting
12
University of Kansas Cancer Center SC
Westwood, Kansas, United States, 66205
Actively Recruiting
13
University of Kansas Cancer Center
Westwood, Kansas, United States, 66205
Actively Recruiting
14
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
15
Beth Israel Deaconess Med Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
16
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
17
University of Michigan
Ann Arbor, Michigan, United States, 48109-2800
Actively Recruiting
18
Uni Of Michigan Health System
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
19
University of Michigan Health System SC CTL019
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
20
Wayne State University-Karmanos Cancer Institute
Detroit, Michigan, United States, 48201
Actively Recruiting
21
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Withdrawn
22
Children s Mercy Hospital
Kansas City, Missouri, United States, 64108
Actively Recruiting
23
Children's Mercy Hospital SC
Kansas City, Missouri, United States, 64108
Actively Recruiting
24
Weill Cornell Medical College
New York, New York, United States, 10065
Withdrawn
25
Duke Unversity Medical Center SC - CTL019B2205J
Durham, North Carolina, United States, 27705
Actively Recruiting
26
Duke Unversity Medical Center
Durham, North Carolina, United States, 27705
Actively Recruiting
27
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229-3039
Actively Recruiting
28
Cinn Children Hosp Medical Center
Cincinnati, Ohio, United States, 45229-3039
Actively Recruiting
29
Ohio ST Compr Cancer Ctr James Hosp
Columbus, Ohio, United States, 43210
Actively Recruiting
30
Oregon Health & Science University
Portland, Oregon, United States, 97239
Actively Recruiting
31
Oregon Health Sciences University
Portland, Oregon, United States, 97239
Actively Recruiting
32
The Childrens Hosp of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
33
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
34
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
35
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
36
Sarah Cannon Research Institute
Nashville, Tennessee, United States, 37203
Actively Recruiting
37
UTSW/Children's Medical Center
Dallas, Texas, United States, 75235
Actively Recruiting
38
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390
Actively Recruiting
39
MD Anderson Cancer Center SC
Houston, Texas, United States, 77030
Actively Recruiting
40
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
41
University of Utah Clinical Trials Office
Salt Lake City, Utah, United States, 84108
Actively Recruiting
42
University of Utah Clinical Trials Office
Salt Lake City, Utah, United States, 84108
Actively Recruiting
43
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792
Actively Recruiting
44
University of Wisconsin Hospital
Madison, Wisconsin, United States, 53792
Actively Recruiting
45
Novartis Investigative Site
Camperdown, New South Wales, Australia, 2050
Actively Recruiting
46
Novartis Investigative Site
Melbourne, Victoria, Australia, 3000
Actively Recruiting
47
Novartis Investigative Site
Melbourne, Victoria, Australia, 3004
Actively Recruiting
48
Novartis Investigative Site
Parkville, Victoria, Australia, 3052
Withdrawn
49
Novartis Investigative Site
Murdoch, Western Australia, Australia, 6150
Actively Recruiting
50
Novartis Investigative Site
Herston, Australia, QLD 4006
Actively Recruiting
51
Novartis Investigative Site
Linz, Austria, 4020
Withdrawn
52
Novartis Investigative Site
Salzburg, Austria, 5020
Actively Recruiting
53
Novartis Investigative Site
Vienna, Austria, 1090
Actively Recruiting
54
Novartis Investigative Site
Vienna, Austria, A 1090
Actively Recruiting
55
Novartis Investigative Site
Ghent, Belgium, 9000
Actively Recruiting
56
Novartis Investigative Site
Hamilton, Ontario, Canada, L8V 1C3
Actively Recruiting
57
Novartis Investigative Site
Toronto, Ontario, Canada, M5G 1X8
Actively Recruiting
58
Novartis Investigative Site
Montreal, Quebec, Canada, H1T 2M4
Actively Recruiting
59
Novartis Investigative Site
Montreal, Quebec, Canada, H3T 1C5
Actively Recruiting
60
Novartis Investigative Site
Beijing, China, 100036
Actively Recruiting
61
Novartis Investigative Site
Copenhagen, Denmark, DK-2100
Actively Recruiting
62
Novartis Investigative Site
Helsinki, Finland, 00029
Actively Recruiting
63
Novartis Investigative Site
Nantes, France, 44093
Actively Recruiting
64
Novartis Investigative Site
Paris, France, 75019
Actively Recruiting
65
Novartis Investigative Site
Paris, France, 75475
Actively Recruiting
66
Novartis Investigative Site
Pierre-Bénite, France, 69495
Actively Recruiting
67
Novartis Investigative Site
Villejuif, France, 94800
Actively Recruiting
68
Novartis Investigative Site
Munich, Bavaria, Germany, 81377
Actively Recruiting
69
Novartis Investigative Site
Regensburg, Bavaria, Germany, 93053
Actively Recruiting
70
Novartis Investigative Site
Würzburg, Bavaria, Germany, 97080
Actively Recruiting
71
Novartis Investigative Site
Frankfurt am Main, Hesse, Germany, 60590
Actively Recruiting
72
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany, 50937
Actively Recruiting
73
Novartis Investigative Site
Leipzig, Saxony, Germany, 04103
Actively Recruiting
74
Novartis Investigative Site
Berlin, Germany, 13353
Actively Recruiting
75
Novartis Investigative Site
Hamburg, Germany, 20246
Actively Recruiting
76
Novartis Investigative Site
Ulm, Germany, 89081
Actively Recruiting
77
Novartis Investigative Site
Chaïdári, Greece, 124 62
Actively Recruiting
78
Novartis Investigative Site
Hong Kong, Hong Kong
Actively Recruiting
79
Novartis Investigative Site
Ramat Gan, Israel, 5265601
Actively Recruiting
80
Novartis Investigative Site
Tel Aviv, Israel, 6423906
Actively Recruiting
81
Novartis Investigative Site
Bologna, BO, Italy, 40138
Actively Recruiting
82
Novartis Investigative Site
Monza, MB, Italy, 20900
Actively Recruiting
83
Novartis Investigative Site
Milan, MI, Italy, 20132
Actively Recruiting
84
Novartis Investigative Site
Milan, MI, Italy, 20133
Actively Recruiting
85
Novartis Investigative Site
Rozzano, MI, Italy, 20089
Actively Recruiting
86
Novartis Investigative Site
Roma, RM, Italy, 00165
Actively Recruiting
87
Novartis Investigative Site
Roma, RM, Italy, 00168
Actively Recruiting
88
Novartis Investigative Site
Fukuoka, Fukuoka, Japan, 812-8582
Actively Recruiting
89
Novartis Investigative Site
Sapporo, Hokkaido, Japan, 060 8648
Actively Recruiting
90
Novartis Investigative Site
Sendai, Miyagi, Japan, 980 8574
Actively Recruiting
91
Novartis Investigative Site
Chuo Ku, Tokyo, Japan, 104 0045
Withdrawn
92
Novartis Investigative Site
Kyoto, Japan, 606 8507
Actively Recruiting
93
Novartis Investigative Site
Amsterdam, North Holland, Netherlands, 1105 AZ
Completed
94
Novartis Investigative Site
Utrecht, Netherlands, 3584 CS
Completed
95
Novartis Investigative Site
Utrecht, Netherlands, 3584 CX
Withdrawn
96
Novartis Investigative Site
Oslo, Norway, 0310
Actively Recruiting
97
Novartis Investigative Site
Oslo, Norway, 0424
Actively Recruiting
98
Novartis Investigative Site
Riyadh, Saudi Arabia, 11211
Actively Recruiting
99
Novartis Investigative Site
Singapore, Singapore, 119074
Actively Recruiting
100
Novartis Investigative Site
Singapore, Singapore, 169608
Actively Recruiting
101
Novartis Investigative Site
Seoul, South Korea, 03080
Actively Recruiting
102
Novartis Investigative Site
Seoul, South Korea, 03722
Actively Recruiting
103
Novartis Investigative Site
Seoul, South Korea, 05505
Actively Recruiting
104
Novartis Investigative Site
Seoul, South Korea, 06351
Actively Recruiting
105
Novartis Investigative Site
Esplugues, Barcelona, Spain, 08950
Actively Recruiting
106
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
Actively Recruiting
107
Novartis Investigative Site
Salamanca, Castille and León, Spain, 37007
Actively Recruiting
108
Novartis Investigative Site
Barcelona, Catalonia, Spain, 08035
Actively Recruiting
109
Novartis Investigative Site
Pamplona, Navarre, Spain, 31008
Actively Recruiting
110
Novartis Investigative Site
Barcelona, Spain, 08041
Actively Recruiting
111
Novartis Investigative Site
Madrid, Spain, 28009
Actively Recruiting
112
Novartis Investigative Site
Madrid, Spain, 28041
Actively Recruiting
113
Novartis Investigative Site
Madrid, Spain, 28046
Actively Recruiting
114
Novartis Investigative Site
Seville, Spain, 41013
Actively Recruiting
115
Novartis Investigative Site
Valencia, Spain, 46010
Actively Recruiting
116
Novartis Investigative Site
Taipei, Taiwan, 10002
Actively Recruiting
117
Novartis Investigative Site
Birmingham, United Kingdom, B15 2TH
Actively Recruiting
118
Novartis Investigative Site
London, United Kingdom, SE5 9RS
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here